Author:

RJ Hamster

ALERT: Drop these 5 stocks before January 2026!

Unsubscribe

A message from Weiss Ratings

Dear Reader,

The first half of 2026 could be very tough for certain stocks …

In fact, our research shows the current volatility is just a preview …

Because what’s coming in 2026 could be much worse.

Specifically, a radical shift is about to hit the market …

And it could send some of America’s most popular stocks crashing down even further.

We’ve identified five stocks you should absolutely avoid as this event plays out …

You’ll want to see this list …

And make sure you don’t own any of these stocks before January 2026 …

Because if you hold on to them — it could mean financial ruin.

To find out more about this incoming market shift …

Including the list of five stocks you must absolutely avoid …

Click here now — before it’s too late.

Sincerely,

Eliza Lasky,
Weiss Advocate

Tuesday’s Featured Content

Bullseye Bounce: Toms Capital Takes Target Stake

By Jeffrey Neal Johnson. Date Posted: 12/30/2025.

Wall Street is always on the hunt for a specific type of story: the turnaround play. These are companies with household names and strong foundations that have temporarily fallen out of favor with the stock market. For investors, these scenarios offer a chance to buy a dollar’s worth of assets for pennies on the dollar. As of late December 2025, Target Corporation (NYSE: TGT) appears to be precisely that kind of opportunity.

Reports confirmed in late December that Toms Capital Investment Management (TCIM), a prominent activist hedge fund, has built a significant stake in the retail sectorplayer. The market’s reaction was swift: Target shares rose about 3.1% immediately after the news, stabilizing in the $97–$99 range. For retail investors, it’s important to understand why this matters. When an activist investor takes a stake, they are not just betting the stock will go up; they intend to make it go up. Activists often demand board seats, strategic changes, or aggressive cost-cutting. Consequently, the arrival of a firm like Toms Capital usually establishes a floor for the stock price — it signals that the period of passive decline is over and a proactive effort to unlock shareholder value has begun.

The Discount Aisle: Why Target Stock is Cheap

To understand the bullish case for Target, investors must first look at how far the stock has fallen. The year 2025 was undeniably difficult for the retailer, with Target’s stock price declining approximately 28% year-to-date, while its primary competitor, Walmart (NASDAQ: WMT), is up about 23%, aided by its dominance in the grocery market. Consumers, squeezed by inflation, pulled back on discretionary purchases like home decor, electronics, and trendy apparel — the very categories where Target earns its highest margins.

Best $19 you’ll spend this year. (Ad)

A former hedge fund manager known for cutting through market noise is briefly opening access to his flagship trading strategy. In a short demo, he explains how his “One Ticker” approach works — and how readers can access the full service for a year at a steep discount.Watch the brief demo here

At a Glance

The arrival of a prominent activist investor signals a proactive effort to unlock shareholder value through strategic operational improvements.
Investors can take advantage of a stock trading at a significant discount to the broader market while collecting a reliable and generous dividend.
Incoming leadership brings deep operational expertise that aligns perfectly with the external push for renewed efficiency and profit growth.

However, this sell-off has created a disconnect between the stock price and the company’s underlying earnings power. Consider the following financial metrics that highlight the value opportunity:

Price-to-Earnings Ratio (P/E): Target is currently trading at a P/E of roughly 12–13x. This means investors are paying about $12 for every $1 of profit the company generates. By comparison, the broader S&P 500often trades around 20x earnings, and larger peers like Walmart command higher multiples. That gap suggests Target is undervalued relative to the market and many competitors.
Dividend Yield: Target pays a substantial dividend, currently yielding between 4.6% and 5.0%, which is attractive in the current market environment.
Dividend King Status: Target has raised its dividend for more than 57 consecutive years. That consistency provides a degree of protection for investors: even if the stock price remains flat in the short term, shareholders can collect nearly a 5% return by holding the shares.

Essentially, the low valuation limits downside risk, while the high dividend pays investors to wait for any turnaround strategies to take effect.

The Fixer: What the Activist Might Demand

The excitement around this news centers on Toms Capital. The firm has a track record of identifying undervalued companies and driving corporate actions that result in meaningful payouts to shareholders. Their approach is rarely passive.

Investors are looking at Toms Capital’s recent wins as a blueprint for what might happen at Target:

Kellanova: Toms Capital built a position in the snack-food giant shortly before it was sold to Mars for nearly $36 billion.
Kenvue: The firm was involved with the consumer-health company prior to its reported $48.7 billion acquisition by Kimberly-Clark in November 2025.

While a full buyout of a massive retailer like Target is less likely than with consumer packaged-goods companies, the playbook remains relevant. Toms Capital is expected to press for changes that directly improve the balance sheet. Those could include:

Portfolio review: Pressuring Target to sell or spin off underperforming brands or business units.
Cost discipline: Demanding deeper cuts to supply-chain expenses than management has previously planned.
Real-estate review: Target owns a significant amount of its real estate; activists often push retailers to monetize these assets to generate immediate cash.

The February Pivot: New Leader, New Pressures

The timing of this investment is a critical data point. It coincides with a leadership transition at Target: long-time CEO Brian Cornell is set to retire on January 31, 2026, and Michael Fiddelke — the current Chief Operating Officer and former Chief Financial Officer — will take the reins on February 1, 2026.

Initially, Wall Street viewed Fiddelke’s appointment as a signal of continuity. However, Toms Capital’s entry changes his mandate. He will not have a traditional honeymoon period to adjust slowly.

This combination of an internal CEO and an aggressive external investor could be an ideal scenario for shareholders:

The operator: Fiddelke knows the business intimately. As a former CFO, he understands the granular details of margins and costs.
The agitator: Toms Capital provides the external pressure needed to make difficult decisions that long-term insiders might avoid.

Rather than fighting the activist, Fiddelke can use the firm’s presence to accelerate necessary changes, such as simplifying operations or exiting unprofitable product lines. That dynamic creates a powerful check-and-balance focused on boosting the stock price in 2026.

Is This the Bottom? Risk, Reward, and Recovery

Investors must always acknowledge risks. Target still faces a bifurcated consumer base that is spending heavily on groceries but cutting back on high-margin discretionary goods. Additionally, macro risks — for example, potential tariffs on imported goods — could pressure margins in the coming year.

However, successful investing is about weighing risk against reward. With Target trading near multi-year valuation lows, much of the risk is already reflected in the price. The entry of Toms Capital fundamentally alters the equation by introducing a clear catalyst for change that was missing throughout 2025.

The combination of a low P/E ratio, a secure and attractive dividend yield, a new CEO focused on operations, and an activist investor with a history of big wins creates a compelling setup. The activist stake has likely put a floor under the stock, offering investors a rare opportunity to buy a blue-chip retailer at a discount with a catalyst for improvement on the immediate horizon.

Thank you for subscribing to StockReport.com, our daily newsletter that highlights a new stock each day.

This email is a sponsored email sent on behalf of Weiss Ratings, a third-party advertiser of StockReport.com and MarketBeat.

11780 US Highway 1,
Palm Beach Gardens, FL 33408-3080
Would you like to edit your e-mail notification preferences or unsubscribe[/link] from our mailing list?Copyright © 2025 Weiss Ratings. All rights reserved.

If you have questions or concerns about your subscription, don’t hesitate to email us at contact@stockreport.com.

If you no longer wish to receive email from StockReport.com, you can unsubscribe.

© 2006-2025 MarketBeat Media, LLC dba StockReport.com. All rights reserved.
345 North Reid Place, Sixth Floor, Sioux Falls, S.D. 57103-7078. U.S.A..

RJ Hamster

BSEM Goes GREEN!!!!

Finally!!! (OTC:BSEM)

Are you seeing this?

We still have a whole day and half left!! Can we see BSEM Break $4.00??

LFG!!

BSEM To the MOON!!

Full Report Below

BioStem Technologies (BSEM): Q3 2025 Earnings Highlight Strong Financial Resilience, Consecutive Profitable Quarters, and there’s Nasdaq Uplisting Potential with a $25.50 Zacks Price Target!

BSEM posts positive adjusted EBITDA for the seventh straight quarter, drives product adoption with clinically validated BioREtain® allografts, and expands access across high-value healthcare channels.

Hello Everyone,

The MedTech sector—where cutting-edge technology meets modern medicine—is among the fastest-growing and most resilient industries today. As global healthcare spending rises and populations continue to age, the demand for advanced medical solutions is surging.

Even in economic slowdowns, healthcare spending tends to remain robust, and many MedTech companies operate in mission-critical markets that are still underpenetrated.

This is exactly where BioStem Technologies (OTC: BSEM) distinguishes itself!

Who is BSEM?

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for advanced wound care.

The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain® processing method. BioRetain® has been developed by applying the latest research in advanced wound care, focused on maintaining growth factors and preserving tissue structure.

BSEM’s quality management systems are accredited by the American Association of Tissue Banks (“AATB”) and adhere to current Good Tissue Practices (cGTP). Its portfolio of quality brands includes AmnioWrap2™, VENDAJE®, VENDAJE AC®, VENDAJE OPTIC®, American Amnion and American Amnion AC™. Each BioStem Technologies placental allograft is processed at the Company’s FDA registeredand AATB accredited site in Pompano Beach, Florida.

Quarterly Earnings Snapshot: Resilience Amid Challenges

BSEM delivered a solid Q3 2025 performance, reporting $10.5 million in net revenue and $0.8 million in GAAP net income.

While revenue slightly declined from $11 million in Q2, the company achieved its seventh consecutive quarter of positive adjusted EBITDA at $2.7 million!

This underscored operational discipline and financial resilience. Gross margin decreased to 88.5% due to a shift toward licensing-based products, and cash balances totaled $27.2 million following land acquisitions and timing of collections.

CEO Jason Matuszewski emphasized that the company remains well-positioned to navigate evolving reimbursement models while pursuing strategic growth initiatives.

“This quarter underscored the resilience of our business model, the discipline of our operations, and the strength of our team as we continued to execute through an evolving reimbursement landscape. BioStem remains well positioned financially, operationally, and clinically to lead through this transition and emerge even stronger,” said Matuszewski.

Validated Technology Driving Adoption

BioStem’s BioREtain® allografts continue to set the standard in regenerative wound care.

Recent Level 1 randomized controlled trial results for diabetic foot ulcers demonstrated superior outcomes versus standard of care.

A pivotal moment for BSEM came with the publication of its groundbreaking clinical trial in the International Journal of Tissue Repair. The peer-reviewed study evaluated the company’s proprietary BioRetain® amnion chorion allograft in patients suffering from non-healing diabetic foot ulcers (DFUs) — one of the most challenging and costly chronic conditions in modern medicine.

The results were extraordinary:

53% probability of complete wound closure using BioRetain®, versus just 31% for standard of care.
Conducted under FDA-level clinical rigor, the study focused on real-world, hard-to-heal ulcers.
Findings demonstrate superior durability, faster healing, and sustained closure — critical metrics for long-term patient outcomes.

Dr. Bert Slade, Chairman of BioStem’s Medical Advisory Board, called the results “strong evidence of treatment benefit,” reinforcing BioStem’s leadership in regenerative tissue technology.

These findings not only validate the company’s proprietary BioRetain® process but also highlight its potential to transform the $27 billion global wound care market.

The venous leg ulcer trial is progressing ahead of schedule, with top-line results expected in Q1 2026. This is just around the corner…

“We are very pleased that this study has demonstrated the effectiveness of BioRetain-processed placental allografts in achieving wound closure in patients with hard-to-heal wounds,” said Jason Matuszewski. “Previously reported comparisons of BioRetain versus competitive technologies have demonstrated its superiority in retaining the natural structural and molecular composition of the native tissue. This study reinforces the clinical performance of our technology.”

Diabetic Foot Ulcers

Diabetic foot ulcers are a serious and chronic condition affecting millions of individuals within the diabetic population.

According to the American Podiatric Medical Association (APMA), a leading authority on foot and ankle health, approximately 15% of people with diabetes will develop foot ulcers.

Alarmingly, 6% of these individuals may require hospitalization due to infections or other complications related to their ulcers. The risks for diabetic patients are substantial, as DFUs are the leading cause of lower extremity amputations in the U.S. Studies indicate that between 14% and 24% of individuals with diabetes who develop foot ulcers will ultimately need an amputation.

The economic burden of these ulcers on healthcare systems is significant, with annual treatment costs estimated between $9 billion and $13 billion in the U.S. alone. As the population continues to age, this financial strain is expected to intensify, underscoring the need for more effective and accessible treatment options such as what BSEM offers.

BioStem expects product margins to remain robust under the new CMS reimbursement model. “We believe BioStem is exceptionally well-positioned to thrive in this environment,” added Matuszewski.

“Our combination of clinically validated products, advanced GMP-compliant manufacturing, and efficient cost structure enables us to compete effectively even as the industry transitions to standardized reimbursement. We anticipate that CMS’s reforms will accelerate provider adoption of technology like BioREtain that delivers proven outcomes and economic value.”

Market Expansion: New Channels Unlock Growth Potential

BSEM is expanding its commercial reach through strategic partnerships, including a Service-Disabled Veteran-Owned Small Business to serve the Department of Veteran Affairs and early traction in state Medicaid programs such as Texas.

The American Amnion launch at the Desert Foot Conference highlights entry into new federal and state markets, with broader access across additional programs planned in 2026. Combined with hospital and ASC initiatives, these moves target a total addressable market estimated at $300–$350 million!

Looking Ahead: Nasdaq Uplisting and Institutional Access

BSEM is actively pursuing a Nasdaq uplisting, targeting mid-2026 following completion of KPMG audits and SEC engagement. This milestone is expected to boost liquidity, attract institutional investors, and increase visibility among MedTech peers.

Combined with a growing patent portfolio, FDA-registered and AATB-accredited facilities, and national reimbursement coverage,BSEM is positioned to capture significant market share in regenerative medicine.

The Bottom Line

With a $25.50 Zacks Small Cap Research price target, BSEMstands out as a high-growth MedTech investment.

The company’s combination of profitable operations, clinically validated products, operational efficiency, and expanding market access positions BSEM for continued success.

While reimbursement changes and pricing pressures present short-term challenges, BSEM’s strong fundamentals, strategic expansion, and Nasdaq uplisting potential make it an attractive opportunity for investors seeking exposure to regenerative medicine.

Start your own research!

Disclaimer

We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of Huge Alerts nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisers, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on Huge Alerts. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. Huge Alerts makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
Some of the content on this website contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which may be beyond a company’s control, and cannot be predicted or quantified, and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. It is hereby noted that forward-looking statements contained herein may include everything other than historical information, involve risk and uncertainties that may affect a company’s actual results of operation. A company’s actual performance could greatly differ from those described in any forward-looking statements or announcements mentioned on this website or the websites contained within. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company’s products; the company’s ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company’s filings with the Securities and Exchange Commission. However, a company’s past performance does not guarantee future results.
Generally, the information regarding a company profiled or discussed on this website is provided from public sources hugealerts.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained through our website or in communications originating from our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and Huge Alerts has no obligation to update any of the information provided. Huge Alerts, its owners, officers, directors, contractors and employees are not responsible for errors and omissions.
From time to time certain content on this website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled on this website may not have approved certain or any statements within the website. Huge Alerts encourages viewers to supplement the information obtained from this website with independent research and other professional advice. The content on this website is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Third Party Web Sites and Other Information This website may provide hyperlinks to third party websites or access to third party content.Huge Alerts, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Huge Alerts control, endorse, or guarantee any content found in such sites. Huge Alerts does not control, endorse, or guarantee content found in such sites. By accessing, viewing, or using the website or communications originating from the website, you agree that Huge Alerts, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Huge Alerts, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. Huge Alerts uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the United States Securities and Exchange Commission (SEC). The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or the Financial Industry Regulatory Authority (FINRA) at: www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/Investors/index.htm.

Income Disclaimer

Testimonials and examples used here are exceptional results which may not apply to the average purchaser. They are not intended to represent or guarantee that anyone will achieve the same or similar results through our service. The use of our information should be based on your own due diligence, and you agree that our company is not liable for any success or failure of your business that is directly or indirectly related to the use of our information. As with any business, your results may vary, and will be based on your individual capacity, business experience and expertise. There are no guarantees concerning the level of success you may experience. Income statements made by our customers are only estimates of what they have earned; there is no guarantee that you will make these levels of income. When using our information you accept the risk that these earnings and income statements differ by individual. There is no assurance that examples of past earnings can be duplicated in the future. There are unknown risks in business and on the internet that we cannot anticipate which can reduce results. We therefore cannot guarantee your future results or success, and are not responsible for your actions.

Huge Alerts has been retained by Biostem Technologies (OTC:BSEM) to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from Biostem Technologies (OTC:BSEM). Questions regarding this website may be sent to editor@hugealerts.com

Huge Alerts has an ongoing agreement with Biostem Technologies (OTC:BSEM) for the total sum of $2,900,500.00 This agreement is for the marketing of Biostem Technologies (OTC:BSEM) which services include the issuance of this release and other opinions that we release concerning of Biostem Technologies (OTC:BSEM). The Owner(s) of huge alerts own 4,365 free trading shares of Biostem Technologies (OTCS:BSEM) and 63,333 restricted shares. for the purpose of this disclaimer assume that the owners of huge alerts will sell every share at any time. Huge Alerts has not investigated the background of Biostem Technologies (OTC:BSEM) the hiring party, or Biostem Technologies (OTC:BSEM) Anyone viewing this newsletter should assume Biostem Technologies (OTC:BSEM) or affiliates of Biostem Technologies (OTC:BSEM) own shares of the Biostem Technologies (OTC:BSEM)) which they plan to liquidate, and further understand that the liquidation of those shares may or may not negatively impact the share price. Huge Alerts has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding Biostem Technologies (OTC:BSEM)

1389 Center Dr
Park City UT 84098
USA

Unsubscribe | Change Subscriber Options

RJ Hamster

The Fed Just Got Kneecapped — Here’s What Happens…

Managing Editor’s Note: The message below comes from our colleagues at Strategic Fortunes. In their latest briefing, they outline a controversial new development they believe could reshape the U.S. monetary landscape. According to their research team, recent federal actions may open the door for a select group of companies to play an outsized role in the evolution of future American currency — a shift they argue could create significant opportunities for early investors. Their analysts suggest that those who understand these changes now could be well positioned for potentially dramatic gains in the years ahead. You can review their full explanation and the details of their thesis below.

Dear Bleeding Edge Reader,

Donald Trump has done it again!

This time, by signing the highly controversial new law S.1582 — he’s kneecapped the Federal Reserve…

And given a select group of chosen companies the legal authority to mint a new form of American money…

Hate it or love it… investors who understand what’s happening and position themselves now could make as much as 40X their money by 2032.

While the rest will be left scrambling in the dust, wondering how they missed it.

Go here now for details — before the wealth transfer begins.

Regards,

Addison Wiggin
Founder, Grey Swan Investment Fraternity

This ad is sent on behalf of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482.
If you would like to unsubscribe from receiving offers for Grey Swan, please click here.

1125 N Charles St, Baltimore, MD 21201
www.brownstoneresearch.com

To ensure our emails continue reaching your inbox, please add our email address to your address book.

No longer wish to receive special offers from us? Manage your preferences here.

RJ Hamster

🍁 News for TELUS, Strathcona Resources, Altius Minerals and…

Ratings changes for Ultragenyx Pharmaceutical, Amgen, Ultragenyx Pharmaceutical, Meta Platforms, reAlpha Tech, Applied Digital, Ultragenyx Pharmaceutical and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.

Unsubscribe.

VIEW MY PORTFOLIO

DECEMBER 30TH, 2025

The Crash Has Already Started (Most Just Don’t See It Yet) (ad)The same seven red flags that preceded the 1929 crash, ’70s stagflation, and the 2008 meltdown are all flashing together right now — long before the headlines catch up. Our free Bellwether Signal Report breaks down each warning in plain language and explains why more Americans are shifting from vulnerable paper assets into hard assets like gold and silver IRAs. If you want to stay ahead of the next major market turn, now is the time to act.

CLAIM YOUR FREE BELLWETHER SIGNAL REPORT BEFORE THE NEXT LEG DOWN

Latest Canadian Market News

The Top Reasons Drone Stocks Could Fly to Higher Highs in 2026

BY BAYSTREET.CA | DECEMBER 30, 2025 01:30 PM

Starlink’s $100 Billion IPO: Your Chance to Invest Early (Ad)

BY PARADIGM PRESS

Father says son killed as Sask. RCMP search for armed suspects on Big Island Lake Cree Nation

BY CBC.CA | DECEMBER 30, 2025 10:51 AM

Constellation Software (CSU:CA) Analysts Forecast 40% Upside

BY THEGLOBEANDMAIL.COM | DECEMBER 30, 2025 10:07 AM

A pre-IPO Play on the Starlink Hype for Under $100? (Ad)

BY PARADIGM PRESS

Custodians of history

BY THEGLOBEANDMAIL.COM | DECEMBER 30, 2025 07:26 AM

Wintry conditions continue to sweep parts of Eastern Canada, Maritimes

BY CBC.CA | DECEMBER 30, 2025 05:50 AM

Canadian Stock Lists

52-Week Highs 52-Week Lows Sector Performance Compare Stocks Penny Stocks Top TSX Stocks Top CVE Stocks Bond Market Holidays Stock Market Holidays

Quick Links

MarketBeat All Access My MarketBeat Account Settings Analyst Ratings Dividend Declarations Earnings Announcements Headlines Insider Trades Trade Stocks with Qtrade Front-Run Buffett’s Shocking Gold Move (ad)A Historic Gold Announcement Is About to Rock Wall Street?

For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

CLICK HERE TO GET GARRETT’S TOP FOUR PICKS NOW.

Analysts’ Downgrades on Tuesday, December 30

Altius Minerals (TSE:ALS) was downgraded by analysts at Raymond James Financial, Inc. from an “outperform” rating to a “market perform” rating. They now have a C$9.50 price target on the stock, up previously from C$9.00. This represents a 76.8% downside from the current price of C$41.03.GDI Integrated Facility Services (TSE:GDI) was downgraded by analysts at TD Securities from a “hold” rating to a “sell” rating. They now have a C$36.60 price target on the stock, up previously from C$31.00. This represents a 1.1% upside from the current price of C$36.21.

Analysts’ Price Target Decreases on Tuesday, December 30

North American Construction Group(TSE:NOA) (NYSE:NOA) had its price target lowered by analysts at CIBC from C$22.00 to C$20.00. This represents a 1.7% upside from the current price of C$19.67.Strathcona Resources (TSE:SCR) had its price target lowered by analysts at Scotiabank from C$40.00 to C$33.00. This represents a 14.0% upside from the current price of C$28.95.TELUS (TSE:T) (NYSE:TU) had its price target lowered by analysts at National Bankshares, Inc. from C$21.50 to C$21.00. They now have an “outperform” rating on the stock. This represents a 17.4% upside from the current price of C$17.89.

VIEW ALL ANALYST RATINGS

Trade this between 9:30 and 10:45 am EST (ad)If you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto trades, you’ll want to see my new e-book, How To Master The Retirement Trade. It reveals a simple, time-based strategy that targets trades designed to play out in as little as 11 hours — no guesswork, no hype.

CLAIM YOUR FREE COPY OF HOW TO MASTER THE RETIREMENT TRADE NOW

Dividends Announced on Tuesday, December 30

Canadian Imperial Bank of Commerce(TSE:CM) (NYSE:CM) announced a quarterly dividend on Monday, December 29th. Shareholders of record on Wednesday, January 28th will be given a dividend of 1.07 per share on Wednesday, January 28th. This represents a c) annualized dividend and a yield of 3.4%. The ex-dividend date is Monday, December 29th. This is a 10.3% increase from Canadian Imperial Bank of Commerce’s previous quarterly dividend of $0.97. IGM Financial Inc. (TSE:IGM) declared a quarterly dividend on Tuesday, December 30th. Shareholders of record on Friday, January 30th will be given a dividend of 0.5625 per share by the financial services provider on Friday, January 30th. This represents a c) annualized dividend and a dividend yield of 3.6%. The ex-dividend date of this dividend is Tuesday, December 30th. This is a 0.1% increase from IGM Financial’s previous quarterly dividend of $0.56. National Bank of Canada (TSE:NA) declared a quarterly dividend on Monday, December 29th. Shareholders of record on Sunday, February 1st will be given a dividend of 1.24 per share by the financial services provider on Sunday, February 1st. This represents a c) annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend is Monday, December 29th. This is a 5.1% increase from National Bank of Canada’s previous quarterly dividend of $1.18.
VIEW DIVIDEND ANNOUNCEMENTS
As crypto prices recover… this coin could soar (ad)One crypto whose metrics keep climbing and climbing…

Discover the one coin set to skyrocket before it’s too late.

DISCOVER THE #1 CRYPTO POISED TO EXPLODE

Canadian Calendars from MarketBeat

Analyst Ratings U.S. Analyst Ratings U.K. Analyst Ratings Corporate Buybacks Cryptocurrencies Dividend Declarations Ex-Dividend Calendar U.S. Dividend Declarations Earnings Announcements U.S. Earnings Announcements Earnings Conference Calls Gap Up/Down Stocks Insider Trades U.S. Insider Trades Initial Public Offerings (IPOs)Most Active Stocks Percentage Gainers/Decliners Sector Performance U.S. Sector Performance Short Interest Stock Splits Unusual Options Volume Unusual Trading VolumeGET 30 DAYS OF MARKETBEAT ALL ACCESS FREESign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:

Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.

START YOUR 30-DAY FREE TRIAL

Thank you for subscribing to MarketBeat!

MarketBeat empowers individual investors to make better trading decisions by delivering up-to-the-minute financial information and objective investment research.

If you have questions about your newsletter, please don’t hesitate to email our South Dakota based support team at contact@marketbeat.com.

If you want to opt out or change which emails you subscribe to, you can manage your subscription preferences or unsubscribe from these emails.

© 2006-2025 MarketBeat Media, LLC.
345 N Reid Pl., Suite 620, Sioux Falls, S.D. 57103-7078. United States of America..

Featured Link: ALERT: Drop these 5 stocks before January 2026! (From Weiss Ratings)

Online brokerage services are offered through Qtrade Direct Investing, a division of Credential Qtrade Securities Inc. Qtrade, Qtrade Direct Investing, and Write Your Own Future are trade names and/or trademarks of Aviso Wealth.

RJ Hamster

Silver is Flashing a New Year 5x Trade Opportunity…

View in browser

“Volatility is a trader’s best friend, and nowhere is this truer than silver.”

Chris “CJ” Johnson, Lead Host & Senior Analyst, Monument Traders Alliance

Chris "CJ" Johnson

Dear Reader,

Silver was one of the hottest trades of 2025, far outpacing what many see as the #1 precious metals trade… gold.

The iShares Silver Trust (SLV) shares are closing out 2025 with returns that are approaching 150% for the year. That more than doubles the returns that gold has put up over the same period of 65%.

To put things further into perspective, Silver has outpaced the average returns of 20% for the Magnificent Seven and only four stocks in the Nasdaq 100 outperformed the “trader’s metal” in 2025.

The last week has seen an increase in volatility for silver as a breakdown in one of the most popular “store of value” trades is falling apart

Bitcoin Entering a Bear Market

Bitcoin is rounding out a disappointment of a year for investors. That’s right, you read that correctly, you should be disappointed in the performance that Bitcoin is turning in for 2025.

Sure, the “Store of Value” cryptocurrency hit all-time high prices just north of $125,000 in October. Sure, we saw the halving event that was suppose to kick off another 100% return for Bitcoin.

And of course, sure… many of the large banks and even central banks are adopting Bitcoin as a strategy for their and their clients assets.

But all of that is still resulting in Bitcoin finishing 2025 in a long-term bear market.

Here’s why.

The last two months have seen Bitcoin drop as much as 36% since hitting that all-time high price of $125k. That alone marks a bear market from the standard definition. But it’s the technical breakdown that should worry you the most.

This week’s lows in bitcoin have taken the cryptocurrency back below its 20-month moving average for the first time since the “coin” fell into a bear market in 2022. That move – coincidentally – also marked the beginning of a long-term bear market for stocks as the Nasdaq 100 notched losses of almost 30% following Bitcoin’s bear market beginning.

There are two things that should interest you about this…

First, the fact that Bitcoin leads the stock market indices into long-term bear market trends is confirmation that Bitcoin IS NOT viewed by investors as a “store of assets”.

Instead, Bitcoin is still considered almost purely a speculative asset that has even more risk than stocks when trading trends turn.

Second… because of that statement, a move further into a bear market trend for Bitcoin will result in a new wave of money moving into silver and gold as investors seek a true hedge against lower prices and volatility in the equity market.

The “run” into gold and silver are in the early stages based on this outlook.

What’s Changed for Silver since 2022 That Makes this A Real 10X Opportunity?

Silver Demand Is Surging Across the Board

Industrial demand is breaking records as solar, EVs, and grid infrastructure consume more silver. Solar PV alone is a silver vacuum and as we have seen, the clean energy movement is not disappearing.
AI/data centers remain the stealth wildcard, driving demand for high-conductivity components – a quiet but growing tailwind.
Investment flows are acceleratingas silver becomes a leveraged bet on gold in risk-off, rate-cut, and dollar-debasement environments.
Sovereign buying is emerging, led by Russia treating silver as a strategic reserve asset — not yet mainstream, but narrative fuel.
Tight, inelastic supply sets up squeeze potential. Most silver is a byproduct metal. Deficits can persist, and forced liquidations hit fast when leverage unwinds.

This surge in demand is adding to the volatility and bullish trend in silver’s price chart.

I always profess that “volatility is a trader’s best friend”. Well, nowhere is this truer than in the market for silver.

According to historical volatility figures, silver is trading at more than 7X the price volatility than gold.

For long-term investors this can be maddening, but that volatility is truly what is driving the Fast, Aggressive and Right Directional (FAR) for silver that is attracting even more investment dollars.

Details on Why NOW is the Time to Act on Silver

This week’s trading volatility in Silver has many investors thinking that it’s time to sell or short the metal, here’s why they are wrong.

I’ve already gone through the fundamental drivers of the 2026 silver trade, let’s look at the technicals…

Silver’s Trend Remains Strong & Friendly: Silver remains in a strong short- and intermediate-term bull market trend that investors should be participating in. Monday’s 9% drop still maintained prices that are still more than 7% higher than the SLV’s 20-day moving average. The silver ETF remains more than 30% above their bullish 50-day moving average.

Buyers Are Rushing in to “Buy the Dip”:Tuesday morning’s response from investors confirms that the market is looking for ANY opportunity to grab the iShares Silver Trust (SLV) on a dip. This is the same activity that has been associated with strong trends in the Magnificent Seven stocks in the past.

SLV Trading Volume Continues to Rise:Trading volume for the iShares Silver Trust is 250% higher than a year ago, confirming that investor interest and trading is growing more robust.

My expectations are that we will see another 100% increase in trading volume as options traders are actively increasing call buying in the SLV option pits.

This means that we are more likely to see this robust bullish trend continue through 2026 as uncertainty, volatility and fundamental strength drives silver prices higher.

How to Trade Silver for 5X Returns in 2026

The first investment approach is simple.

Don’t go to Costco or your local coin shop, open your brokerage account app and consider the iShares Silver Trust (SLV) as a long-term trade for silver.

You are not guaranteed to have silver delivered to you by holding the GLD shares.

If you want to tuck an ingot or coins away in your safe or an old Hills Brothers coffee can buried in the back yard, the SLV shares are not for you.

If you’re interested in being able to liquidate your silver holding anytime that the market is open and have that cash available then the SLV may be the right way to hold silver.

It’s a simple buy and hold trade. Ignore the volatility and focus on the long-term trend, that’s it.

Current prices are $68.74 and my low-end target for the SLV shares for 2026 is $100. That’s approximately 45% return from today’s prices, but again…. That’s my low-end. I see real potential for SLV shares to reach $150-$175 (160% gains) in the new year.

As it looks right now, Silver is only in the fifth inning of a nine-inning game when it comes to the long-term trend.

Turn that Trend into Your Leveraged Friend

More aggressive traders may want to leverage the move in the Gold Shares using options.

Don’t bother with short-term one-month or even six-month expiration options. The trend is your friend here.

Consider the January 2027 expiration LEAPs on the iShares Silver Trust (SLV).

You’ll get the advantage of leveraging the long-term trend along with the smoothing effects of a longer-term option.

This means that the short-term volatility won’t keep you staring at your screen.

The January 15, 2027 SLV $70 calls are currently trading for $1,350 per contract. That’s the price of about 20 shares of the SLV, but you control 100 shares with the option.

This option would be worth a minimum of $3000 in intrinsic value if the SLV shares hit that low-end $100 target anytime between now and January 15, 2027. That’s a return of 122% on the long-dated option compared to just 45% on the ETF itself.

That return jumps to 492% if the price of SLV shares hits my stretch goal of $150 at anytime between now and January 15, 2027.

The potential results of this leveraged trade on silver are detailed in the tables below, but I think you’ll agree that the January 2027 call option is far more attractive to long-term investors.

Both the buy and hold and the long-term call option are effective ways to position for what looks to be another banner year for silver.

As always, please make sure to educate and get experience using options as an investment before executing the strategy “real time” in an account. Logo

YOUR ACTION PLAN

To help you understand options at the foundational level, I recently recorded several videos covering the basics of options trading.

These videos cover call options, put options and key trading concepts.

If you’re a beginner trader, these will set you up for successful options trading.

Click the links below to learn the basics, and be sure to subscribe to the Monument Traders Alliance YouTube channel if they’re helpful for you.

Video links are below…

Know These Options Concepts Video

What is a Call Option?

What is a Put Option?

TESTIMONIAL TUESDAY

“In AMZN 19 Dec 230 calls @ $4.15. Out @ $5.50 for a 32% overnight gain. Thanks Bryan. Thanks War Room.”
– Tlee9999

“I took the TSLA lotto late, but just closed for 84% win in 15 minutes! Thanks NateB”
– AlphaD

“Thanks Karim – out (AKAM) @ 8.80 for 45% (in 249 trading days).”
– JoeS

INSIGHTS YOU MAY HAVE MISSED

Silver’s Having A Moment. Don’t Screw This Up.

Silicon Isn’t Dying – It’s Evolving Into a Massive Opportunity

Happy Holidays from Monument Trader’s Alliance

How One Graduate Class Changed Everything I Know About Market Behavior

Last Chance to save $50 sitewide

Maui Jim - $50 Off Sitewide Our Our best off for 2025! Enjoy $50 towards your next purchase. Expires 12/31/25. U.S. only. If you are outside the U.S. and would like to receive a discountt code, please contact customer service by visiting the bottom of the mauijim.com home page to obtain contact information. Use code below at checkout on mauijim.comj

Promotional Card Number: 2202960438475396
PIN: A49P 30 days free returns, PolarizedPlus2 Technology, 2 Year Warranty

Terms & Privacy

2025 Maui Jim, Inc. Lahaina, Hawaii

Maui Jim | One Aloha Lane

Peoria | IL | 61615 | United States

Manage Preferences / Unsubscribe

View in browser

RJ Hamster

The Anatomy of a Perfect Call

December 30, 2025 | Read Online

I’m sitting here on the second to last trading dayof the year, looking at silver trading north of $77 as I write this, and honestly? This is what it feels like when you read the charts right.

Back on January 9th, when I laid out what I called a “golden opportunity in gold and silver,” I wasn’t throwing darts at a board. Silver was trading around $30.

I told TheoTrade Chatroom Members it could hit $46-48, maybe even $50. Gold was around $2,660. My top three mining stocks—AGI was at $23, KGC was at $11, GFI was at $18.

I was following patterns I’ve been tracking for years. Every one of these calls came from the same place – clean charts, obvious trends, and knowing what to look for when precious metals are setting up to rip.

As of this writing, silver is up over 155% for the year. My three mining picks averaged over 150% returns. That’s what happens when the setup is right and you don’t overthink it.

The Three Charts I Couldn’t Ignore

Let me tell you what I told TheoTrade Chatroom Members in January that made these picks obvious:

Alamos Gold (AGI): I called $37-38. It’s trading around $39.30.
Look, I’ve seen a lot of mining charts over the years.

Most of them are choppy garbage that’ll give you whiplash. But AGI? Clean uptrend since 2022. Higher highs, higher lows.

I specifically called out that cup and handle pattern because it was textbook beautiful. When I see a chart that clean in the mining space, I pay attention.

Most miners can’t hold a trend to save their lives. AGI kept up with gold’s performance. That told me everything.

Kinross Gold (KGC): I called $21-22. It’s trading around $28.90.
Same story here – higher highs and higher lows since the 2022 bottom. But what really got my attention was watching KGC buck the trend when other miners were getting chopped up.

That’s relative strength. When a stock refuses to go down with its peers, it’s telling you something. I’ve been trading long enough to listen when the market speaks that clearly.

Gold Fields (GFI): I called $29-30. It’s trading around $44.30.
This one had the prettiest cup and handle I’d seen in months. I remember saying “this is my cup of tea” because the pattern was so obvious it almost seemed too easy. Sometimes the best trades are the ones that look too simple.

When you see a setup that clean, you don’t question it. You act on it.

How the Ratio Chart Called It All

Here’s what most people completely missed: I wasn’t just picking random mining stocks. I was watching the gold-to-silver ratio like a hawk.

I showed everyone that chart back in January – when this ratio is high, silver starts to outperform gold.

When silver outperforms gold, you’re usually in the sweet spot where miners explode higher.

It’s not complicated. The pattern repeats itself over and over in precious metals cycles.

Gold’s up 64%, silver’s up over 155%. The ratio collapsed exactly like the chart said it would.

More importantly, this told me we were entering the phase where the miners would outrun the metals themselves. Which is exactly what happened.

The technical picture in January was screaming if you knew how to look.

Gold breaking out of consolidation. Silver showing relative strength. The Philadelphia Gold and Silver Index in a clean multi-year uptrend.

But the real edge was recognizing where we were in the cycle.

I’ve watched enough precious metals bull markets to know the signs. When you see clean technical setups in quality miners while the underlying metals are setting up for breakouts, you don’t hesitate.

I’m a trend trader.

Always have been. When I see higher highs and higher lows, especially in names that are bucking the trend of their peers, that gets my attention. When those same names are showing textbook continuation patterns, that gets my money.

Could I have predicted silver would hit $77? No chance. But I didn’t need to. The charts told me these names were setting up for significant moves.

My job wasn’t to predict the exact magnitude – it was to identify the highest probability setups and position accordingly.

That’s the difference between trading and gambling. I don’t need to be precisely right. I need to be directionally right with names that have the technical backing to deliver when the sector moves.

What 2026 Looks Like

This year proved something I’ve believed for over a decade: if you can read trends correctly and identify the strongest names in strengthening sectors, the market will reward you.

It’s not about picking the perfect entry or predicting exact tops. It’s about recognizing when all the pieces are aligning.

The same approach that identified these winners is already highlighting some interesting opportunities for 2026.

Different sectors, different patterns, but the same mechanical way of reading what the market is telling me.

In the next week, I’ll be sharing my top ideas for 2026 in the TheoTrade Chatroom.

The technical work is almost done, and there are some setups developing that have me genuinely excited about what’s ahead.

2025 reminded me why I love this business.

When you read the charts right and position accordingly, the market pays you for being prepared. The question is whether you’ll be ready when the next obvious setup presents itself.

Stay tuned. The best opportunities often follow the best years.

Gianni Di Poce

P.S. Can’t wait till next week? I’m going live on Friday at 12 pm for something really cool… Click here for all the details. The Market You Learned On Doesn’t Exist Anymore

Update your email preferences or unsubscribe here

© 2025 Disclaimer: Neither TheoTrade or any of its officers, directors, employees, other personnel, representatives, agents or independent contractors is, in such capacities, a licensed financial adviser, registered investment adviser, registered broker-dealer or FINRA|SIPC|NFA-member firm. TheoTrade does not provide investment or financial advice or make investment recommendations. TheoTrade is not in the business of transacting trades, nor does TheoTrade agree to direct your brokerage accounts or give trading advice tailored to your particular situation. Nothing contained in our content constitutes a solicitation, recommendation, promotion, or endorsement of any particular security, other investment product, transaction or investment.Trading Futures, Options on Futures, and retail off-exchange foreign currency transactions involves substantial risk of loss and is not suitable for all investors. You should carefully consider whether trading is suitable for you in light of your circumstances, knowledge, and financial resources. You may lose all or more of your initial investment. Opinions, market data, and recommendations are subject to change at any time. Past Performance is not necessarily indicative of future results.

PO Box 24790
Christiansted, Virgin Islands 00824, United States of AmericaTerms of Service

RJ Hamster

Brad’s Deals. There’s a real-life human behind every post.

A smarter way to save with exclusives & expert-picked deals from thousands of trusted retailers to give you the advantage when you shop.
— Read on www.bradsdeals.com/

RJ Hamster

A private letter from Donald Trump Jr…

Hey there, it’s Micah here.

As the year winds down, something interesting happens.

The noise fades a bit. The screens get quieter. The urgency loosens its grip.

And for a brief window, you get something most traders almost never give themselves.

Honesty.

This time of year has a way of pulling us out of reaction mode and into reflection. You start thinking about what worked, what didn’t, and why certain patterns seem to repeat no matter how motivated you were at the start of the year.

That’s what I want to talk about today.

Not strategies. Not indicators. Not setups.

But a simple idea that most traders never truly confront.

The market is not your enemy.

The market is a mirror.

Most traders believe the market is something to beat. Something to outsmart. Something to conquer with better tools, better timing, or better information.

But after watching thousands of traders over the years, here’s the uncomfortable truth.

Two traders can look at the exact same chart. The same levels. The same indicators. The same market conditions.

And walk away with completely different results.

One stays patient. One panics.

One follows their plan. One second guesses and overrides it.

One accepts a small loss. One moves a stop and turns it into something bigger.

The difference is not the market.

It is what the market pulls out of them.

The market has a way of exposing impatience. It reveals fear when price moves against you. It exposes ego when you need to be right. It highlights insecurity when you keep searching for a new system after every losing streak.

The market does not cause these behaviors.

It reveals them.

That’s why so many traders feel like they are constantly fighting. Fighting the market. Fighting their emotions. Fighting themselves.

They are trying to fix an internal problem with an external solution.

New indicators. New strategies. New tools.

And for a short while, it feels like progress.

Until pressure shows up again.

Then the same reactions appear. The same mistakes surface. The same frustration creeps back in.

This is why access to information has never been the real edge.

Today, traders have more data, faster platforms, and better tools than at any point in history.

Yet consistency remains rare.

If information alone solved the problem, the failure rate would be dropping every year.

It is not.

Because the real bottleneck is not what you know.

It is how you behave when uncertainty shows up.

And uncertainty always shows up.

Here’s the part most people avoid.

The market is neutral. It does not judge you. It does not punish you. It does not reward you.

It simply reflects how you respond under pressure.

When you hesitate, it reflects hesitation. When you rush, it reflects impatience. When you avoid losses, it reflects fear. When you abandon your plan, it reflects a lack of trust in yourself.

That can be hard to look at.

But it is also incredibly freeing.

Because once you understand this, you stop trying to control the market.

And you start working on the only thing you actually can control.

How you show up.

This is why the end of the year matters.

Not because of calendar dates. Not because of resolutions.

But because it gives you a rare pause to ask better questions.

What did the market reflect back to me this year? Where did I repeat the same behaviors? What situations consistently knocked me off balance? Where did I abandon my own rules? Where did emotion override process?

If you are willing to look honestly, the answers are usually clear.

And if this idea makes you slightly uncomfortable, that is not a bad sign.

That is the mirror starting to work.

More soon.

Trade On,
Micah

Micah Lamar
CEO WallStreet.io
Micah@WallStreet.io

Questions? Please email us at Support@WallStreet.io or

Chat with us 1-on-1 at WallStreet.io

Manage Email Notifications

Thank you for being a part of our community. Please use the social links below and spread the word. We appreciate you! Thanks in advance.

Author:

Bullseye Bounce: Toms Capital Takes Target Stake

The Discount Aisle: Why Target Stock is Cheap

At a Glance

The Fixer: What the Activist Might Demand

The February Pivot: New Leader, New Pressures

Is This the Bottom? Risk, Reward, and Recovery

Share this:

Like this:

Share this:

Like this:

Share this:

Like this:

DECEMBER 30TH, 2025

Latest Canadian Market News

Canadian Stock Lists

Quick Links

Analysts’ Downgrades on Tuesday, December 30

Analysts’ Price Target Decreases on Tuesday, December 30

Dividends Announced on Tuesday, December 30

Canadian Calendars from MarketBeat

Share this:

Like this:

Chris “CJ” Johnson, Lead Host & Senior Analyst, Monument Traders Alliance

Bitcoin Entering a Bear Market

Here’s why.

What’s Changed for Silver since 2022 That Makes this A Real 10X Opportunity?

Details on Why NOW is the Time to Act on Silver

How to Trade Silver for 5X Returns in 2026

Turn that Trend into Your Leveraged Friend

YOUR ACTION PLAN

TESTIMONIAL TUESDAY

INSIGHTS YOU MAY HAVE MISSED

Share this:

Like this:

Share this:

Like this:

The Three Charts I Couldn’t Ignore

How the Ratio Chart Called It All

What 2026 Looks Like

Share this:

Like this:

Share this:

Like this:

Share this:

Like this:

Share this:

Like this: